Gastroenterology and Hepatology from Bed to Bench

Pantiga C, Rodrigo LR, Cuesta M, Lopez L, Arias JL. Cognitive defi cits in patients with hepatic cirrhosis and in liver transplant recipients. J Neuropsychiatry Clin Neurosci 2003;15:84-9.

Marquez-Aguirre AL, Canales-Aguirr, AA, Gomez-Pinedo U, Galvez-Gastelum FJ. Molecular aspects of hepatic encephalopathy. Neurologia 2010;25:239-47.

Ferenci p. Hepatic encephalopathy. Gastroenterol Rep 2017;5:138-47.

Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. BMJ 1988;297:1501-4.

Bergasa NV, Rothman RB, Vergalla J, Xu H, Swain MG, Jones EA. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol 1992;15:220-4.

Glaser S, Alvaro D, Roskams T, Phinizy JL, Stoica G, Francis H, et al. Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity. Am J Physiol Gastrointest Liver Physiol 2003;284:683-94.

Zimatkin SM, Baraban OV, Emel’yanchik SV. Metabolic changes in rat brain histaminergic neurons during subhepatic cholestasis. Neurosci Behav Physiol 2008;38:807-10.

Zarrindast MR, Hoseindoost S, Nasehi, M. Possible interaction between opioidergic and cholinergic systems of CA1 in cholestasis-induced amnesia in mice. Behav Brain Res 2012;228:116-24.

Yurdaydin C, Hortnagl H, Steindl P, Zimmermann C, Pifl C, Singer EA, et al. Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure. Hepatology 1990;12:695-700.

Hosseini N, Nasehi M, Radahmadi M, Zarrindast MR. Effects of CA1 glutamatergic systems upon memory impairments in cholestatic rats. Behav Brain Res 2013;256: 636-45.

Rodriguez-Garay EA. Cholestasis: human disease and experimental animal models. Ann Hepatol 2003;2:150-8.

Dutta S, Chakraborty AK, Dey P, Kar P, Guha P, Sen S, et al. Amelioration of CCl4 induced liver injury in swiss albino mice by antioxidant rich leaf extract of Croton bonplandianus Baill. PLoS One 2018;13:e0196411.

Bearn J, Wessely S. Neurobiological aspects of the chronic fatigue syndrome. Eur J Clin Invest 1994; 24:79-90.

Burak KW, Le T, Swain MG. Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats. Gastroenterology 2002;122:681-8.

Forton DM, Patel N, Prince M, Oatridge A, Hamilton G, Goldblatt J, et al. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut 2004;53:587-92.

Eslimi D, Oryan S, Nasehi M, Zarrindast MR. Effects of opioidergic systems upon anxiolytic-like behaviors induced in cholestatic rats. Eur J Pharmacol 2011:16,670:180-5.

Zarrindast MR, Eslimi Esfahani D, Oryan S, Nasehi M Torabi Nami M. Effects of dopamine receptor agonist and antagonists on cholestasis-induced anxiolytic-like behaviors in rats. Eur J Pharmacol 2013;702:25-31.

Zhang YT, Zheng QS, Pan J, Zheng RL. Oxidative damage of biomole- cules in mouse liver induced by morphine and protected by antioxidants. Basic. Clin Pharmacol Toxicol 2004;95:53-8.

Gelenberg AJ. Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment. Prim Care Companion J Clin Psychiatry 2000;2:49-54.

Marzioni M, Alpini G, Saccomanno S, de Minicis S, Glaser S, Francis H, et al. Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis. Gastroenterology 2006;130:1831-47.

Bergasa NV, Sabol SL, Young WS, Kleiner DE, Jones EA. Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am J Physiol 1995;268:346-54.

Zarrindast MR, Navaeian M, Nasehi M. Influence of three-day morphine treatment upon impairment of memory consolidation induced by cannabinoid infused into the dorsal hippocampus in rats. Neurosci Res 2011;69:51-9.

Zarrindast MR, Rostami P, Zarei M, Roohbakhsh A. Intracerebroventricular effects of histaminergic agents on morphine-induced anxiolysis in the elevated plus-maze in rats. Basic. Clin. Pharmacol. Toxicol 2005;97:276-81.

Zhang HT, Xu ZM, Luo P, Qin BY. Anxiogenic effect of naltrexone in social interaction test in rats. Zhongguo. Yao Li Xue Bao 1996;17:314-7.

Zarrindast MR, Mousa-Ahmadi E. Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice. Eur J Pharmacol 1999;381:129-33.

Sasaki K, Fan LW, Tien LT, Ma T, Loh HH, Ho IK. The interaction of morphine and gamma-aminobutyric acid (GABA)ergic systems in anxiolytic behavior: using mu-opioid receptor knockout mice. Brain Res Bull 2002;57:689-94.

Kahveci N, Gulec G, Ozluk K. Effects of intracerebroventricularly-injected morphine on anxiety, memory retrieval and locomotor activity in rats: involvement of vasopressinergic system and nitric oxide pathway. Pharmacol Biochem Behav 2006;85:859-67.

Zarrindast MR, Babapoor-Farrokhran S, Rezayof A. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Life Sci 2008;82:1175-81.

Nasehi M, Mafi F, Oryan S, Nasri S, Zarrindast MR. The effects of dopaminergic drugs in the dorsal hippocampus of mice in the nicotine-induced anxiogenic-like response. Pharmacol Biochem Behav 2011;98:468-73.

Sealfon SC, Olanow CW. Dopamine receptors: from structure to behavior. Trends Neurosci 2000;23:S34-40.

Rezayof A, Alijanpou, S, Zarrindast MR, Rassouli Y. Ethanol state-dependent memory: involvement of dorsal hippocampal muscarinic and nicotinic receptors. Neurobiol Learn Mem 2009;89:441-7.

Radke AK, Rothwell PE, Gewirtz JC. An anatomical basis for opponent process mechanisms of opiate withdrawal. J Neurosci 2011;31:7533-9.

Garcia AM, Martinez R, Brandao ML, Morato S. Effects of apomorphine on rat behavior in the elevated plus-maze. Physiol Behav 2005;85:440-7.

Zarrindast MR, Dorrani M, Lachinani R, Rezayof A. Blockade of dorsal hippocampal dopamine receptors inhibits state dependent learning induced by cannabinoid receptor agonist in mice. Neurosci Res 2010;67:25-32.

Zarrindast MR, Khalifeh S, Rezayof A, Rostami P, Aghamohammadi Sereshki A, Zahmatkesh M. Involvement of rat dopaminergic system of nucleus accumbens in nicotine-induced anxiogenic-like behaviors. Brain Res 2012;1460:25-32.

Zarrindast MR, Bananej M, Khalilzadeh A, Fazli-Tabaei S, Haeri-Rohani A, Rezayof A. Influence of intracerebroventricular administration of dopaminergic drugs on morphine state-dependent memory in the step- down passive avoidance test. Neurobiol Learn Mem 2006; 86:286-92.

Zarrindast MR, Rezayof A. Morphine state-dependent learning: sensitiza- tion and interactions with dopamine receptors. Eur J Pharmacol 2004;497:197-204.

Narita M, Matsushima Y, Niikura K, Takagi S, Nakahara K, Kurahashi K, et al. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in mu-opioid-induced place preference. Addict Biol 2010;15:434-47.

Mallajosyula JK, Kaur D, Chinta SJ, Rajagopalan S, Rane A, Nicholls DG, et al. MAO-B elevation in mouse brain astrocytes results in Parkinson’s pathology. PLoS One 2008;3:1616.

Zeneroli ML, Baraldi M, Ventura E, Vezzelli C, Tofanetti O, Germini M, et al. Alterations of GABA-A and dopamine D-2 brain receptors in dogs with portal-systemic encephalopathy. Life Sci 1991;48:37-50.

Nikolaus S, Antke C, Beu M, Muller HW. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders– results from in vivo imaging studies. Rev Neurosci 2010;21:119-39.

Zarrindast MR, Solati J, Oryan S, Parivar K. Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats. Pharmacology 2008c;82:276-84.

Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984;65:305-11.

Aronson DC, Chamuleau RA, Frederiks WM, Gooszen HG, Heijmans HS, James J. Reversibility of cholestatic changes following experimental common bile duct obstruction: fact or fantasy. J Hepatol 1993;18:85-95.

Romero-Gomez M, Cordoba J, Jover R, del Olmo JA, Ramirez M, Rey R. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007;45:879-85.

Zarrindast MR, Bahreini T, Adl M. Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice. Pharmacol Biochem Behav 2002;73:941-9.

Rezayof A, Zatali H, Haeri-Rohani A, Zarrindast MR. Dorsal hippocampal muscarinic and nicotinic receptors are involved in mediating morphine reward. Behav Brain Res 2006;166:281-90.

Garcia-Ayllon MS, Silveyra MX, Candela A, Compan A, Claria J, Jover R. Changes in liver and plasma acetylcholinesterase in rats with cirrhosis induced by bile duct ligation. Hepatology 2006;43:444-53.

Eidi M, Zarrindast MR, Eidi A, Oryan S, Parivar K. Effects of histamine and cholinergic systems on memory retention of passive avoidance learning in rats. Eur J Pharmacol 2003;465:91-6.

Prado VF, Martins-Silva C, de Castro BM, Lima RF, Barros DM, Amaral E. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 2006;51:601-12.

Huerta PT, Lisman JE. Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic state. Nature 1993;364:723-5.

Kirby BP, Rawlins JN. The role of the septo-hippocampal cholinergic projection in T-maze rewarded alternation. Behav Brain Res 2003;143:41-8.

Imperato A, Obinu MC, Casu MA, Mascia MS. Carta G, Gessa GL. Chronic morphine increases hippocampal acetylcholine release: possible relevance in drug dependence. Eur J Pharmacol 1996;302:21-6.

Roma MG, Crocenzi FA, Sanchez Pozzi EA. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects. Clin Sci 2008;114:567-88.

Weissenborn K, Heidenreich S, Giewekemeyer K, Ruckert N, Hecker H. Memory function in early hepatic encephalopathy. J Hepatol 2003;39:320-5.

Betterton RT, Broad LM, Tsaneva-Atanasova K, Mellor JR. Acetylcholine modulates gamma frequency oscillations in the hippocampus by activation of muscarinic M1 receptors. Eur J Neurosci 2017;45:1570-85.

Khajehpour L, Rezayof A, Zarrindast MR. Involvement of dorsal hippocampal nicotinic receptors in the effect of morphine on memory retrieval in passive avoidance task. Eur J Pharmacol 2008;584:343-51.

Azami NS, Piri M, Oryan S, Jahanshahi M, Babapour V, Zarrindast MR. Involvement of dorsal hippocampal alpha-adrenergic receptors in the effect of scopolamine on memory retrieval in inhibitory avoidance task. Neurobiol Learn Mem 2010;93:455-62.

Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217:408-14.

Fibiger HC. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci 1991;14:220-3.

Jensen KP, DeVito E, Yip S, Carroll KM, Sofuoglu M. The Cholinergic System as a Treatment Target for Opioid Use Disorder. CNS Drugs 2018;32:981-96.

Haber SN, Knutso B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010;35:4-26.

Zarrindast MR, Ebrahimi-Ghiri M, Rostami P, Rezayof A. Repeated pre-exposure to morphine into the ventral pallidum enhances morphine- induced place preference: involvement of dopaminergic and opioidergic mechanisms. Behav Brain Res 2007;181:35-41.

Rezayof A, Golhasani-Keshtan F, Haeri-Rohani A, Zarrindast MR. Morphine-induced place preference: involvement of the central amygdala NMDA receptors. Brain Res 2007;1133:34-41.

Sahraei H, Etemadi L, Rostami P, Pourmotabbed A, Zarrindast MR, Shams J. GABAB receptors within the ventral tegmental area are involved in the expression and acquisition of morphine-induced place preference in morphine-sensitized rats. Pharmacol Biochem Behav 2009;91:409-16.

Nicoll J, Axiotis CA, Bergasa NV. The delta opioid receptor 1 is expressed by proliferating bile ductules in rats with cholestasis: implications for the study of liver regeneration and malignant transformation of biliary epithelium. Med Hypotheses 2005;65:1099-105.

Ebrahimi-ghiri M, Nasehi M, Rostami P, Mohseni-Kouchesfehani H, Zarrindast MR. The effect of cholestasis on rewarding and exploratory behaviors induced by opioidergic and dopaminergic agents in mice. Arch Iran Med 2012;15:617-24.

Zarrindast MR, Habibi M, Borzabadi S, Fazli-Tabaei S, Hossein Yahyavi S, Rostamin P. The effects of dopamine receptor agents on naloxone-induced jumping behaviour in morphine-dependent mice. Eur J Pharmacol 2002;451:287-93.

Rezayof A, Zarrindast MR, Sahraei H, Haeri-Rohani, A. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. J Psychopharmacol 2003;17:415-23.

Gyertyan I, Gal K. Dopamine D3 receptor ligands show place conditioning effect but do not in_uence cocaine-induced place preference. Neuroreport 2003;14:93-8.

Zarrindast MR, Nasehi M, Rostami P, Rezayof A, Fazli-Tabaei S. Repeated administration of dopaminergic agents in the dorsal hippocampus and morphine-induced place preference. Behav Pharmacol 2005;16:85-92.

Nasehi M, Sahebgharani M, Haeri-Rohani A, Zarrindast MR. Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. Neurobiol. Learn Mem 2009;92: 391-9.

Nasehi M, Tackallou SH, Hasani I, Nasehi M. Cholestasis impaired spatial and non-spatial novelty Involvement of opioidergic and nitrergic systems in memory acquisition and exploratory behaviors in cholestatic mice. Behav Pharmacol 2013;24:180-94.

Zarrindast MR, Naghdi-Sedeh N, Nasehi M, Sahraei H, Bahrami F, Asadi F. The effects of dopaminergic drugs in the ventral hippocampus of rats in the nicotine-induced anxiogenic-like response.Neurosci. Lett 2010b;475:156-60.

Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO. Cannabidiol—recent advances. Chem Biodivers 2007;4:1678-92.

Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM. Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol 2009;51:528-34.

Eslimi Esfahani D, Oryan S, Nabiuni m, Karimian Peiro M. The role of cholestasis in brain hippocampus trauma in male Wistar rat. Nova Biologica Reperta 2017;4:128-36.

Felipo V, Butterworth RF. Neurobiology of ammonia. Prog. Neurobiol 2002;67:259-79.

Jover R, Rodrigo R, Felipo V, Insausti R, Saez-Valero J, García-Ayllón M. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis. Hepatology 2006;43:1257-66.

Houghoghi V, Rezayof A, Zyaian S, Zarrindast MR. Intradorsal hippocampal microinjection of lithium reverses morphine-induced impairment of memory in mice: interactions with dopamine receptor mechanism(s). Behav Pharmacol 2009;20:680-7.

Zarrindast MR, Navaeian M, Nasehi M. Influence of three-day morphine-treatment upon impairment of memory consolidation induced by cannabinoid infused into the dorsal hippocampus inrats. Neurosci Res 2010;69:51-9.

Zarrindast MR, Lahmi A, Ahamadi S. Possible involvement of mu-opioid receptors in effect of lithium on inhibitory avoidance response in mice. J Psychopharmacol 2008;22:865-71.

Bergasa NV, Zhou J, Ravi J, Shi Q. The opioid peptide analogD-Ala2-Met-enkephalinamide decreases bile flow by a central mechanism. Peptides 1999;20:979-86.

Traynor J. mu-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology. Drug Alcoh. Depend 2012;121:173-80.

Bals-Kubik R, Herz A, Shippenberg TS. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology 1989;98:203-6.

Schindler CW, Gormezano I, Harvey JA. Effects of morphine, ethylketocyclazocine, U-50,488H and naloxone on the acquisition of a classically conditioned response in the rabbit. J Pharmacol Exp Ther 1987;243:1010-7.

Peregud DI, Vorontsova ON, Yakovlev AA, Panchenko LF, Gulyaeva NV. Changes in anxiety in abstinence correlate with the state of the nigrostriatal system in the rat hippocampus. Neurosci Behav Physio 2008;38:443-8.

Nasehi M, Amin Yavari S, Zarrindast MR. Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice. Psychopharmacology 2013;227:553-66.

Vallone D, Picetti R, Borrelli E. Structure and function of dopamine receptors. Neurosci Biobehav Rev 2000;24:125-32.

Calabrese EJ. Dopamine: biphasic dose responses. Crit Rev Toxicol 2001;31:563-83.

Dilts RP, Kalivas PW. Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D-penicillamine, 5-D-penicillamine] encephalin (125I-DPDPE). Synapse 1990;6: 121-32.

Izquierdo I, Netto CA. Dual action of post-training naloxone on memory. Behav Neural Biol 1990;53:140-6.

Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994;46: 157-203.

Tao R, Auerbach SB. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. J Pharmacol Exp Ther 2002;303:549-56.

Hosseini N, Alaei H, Zarrindast MR, Nasehi M, Radahmadi M. Cholestasis progression effects on long-term memory in bile duct ligation rats. Adv Biomed Res 2014;3: 334-401.

Tarter RE, Arria AM, Carra J, Van Thiel DH. Memory impairments concomitant with nonalcoholic cirrhosis. Int J Neurosci 1987;32:853-9.

Huang LT, Chen CC, Sheen JM, Chen YJ, Hsieh CS, Tain YL. The interaction between high ammonia diet and bile duct ligation in developing rats: Assessment by spatial memory and asymmetric dimethylarginine. Int J Dev Neurosci 2010;28:169-74.

Javadi-Paydar M, Ghiassy B, Ebadian S, Rahimi N, Norouzi A, Dehpour AR. Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats. Behav Pharmacol 2013;24:195-206.

Agen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM. Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation. Br J Pharmacol 2010;159:950-7.

Morris R, Garrud P, Rawlins J, O'Keefe J. Place navigation impaired in rats of ethanol-induced gastric damage in cholestatic rats. Fundam Clin Pharmacol 2001;15:181-7.

Morrison SF, Nakamura K. Central neural pathways for thermoregulation. Front Biosci 2001;16:74-104.

Osaka T. Hypoxia-induced hypothermia mediated by noradrenaline and nitric oxide in the rostromedial preoptic area. Neuroscience 2011;179:170-8.

Gharoony F, Oryan S, Nabiuni M, Eslimi Esfahani D, Hosseinynia TS, Karimian Peiro M, et al. The histopathological effects of cholestasis on hypothalamic paraventricular and supraoptic nucleus on male wistar rats. Nova Biologica Reperta 2015;1:77-85.

Oryan Sh, Nabiuni M, Eslimi Esfahani D. Effects of Cholestasis on Aquaporin 4 Choroid Plexus of Male Wistar Rat. J Animal Researches 2017;30:134-44.

Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM, Herman MM, et al. Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 2003;116:127-37.

Hasegawa H, Meeusen R, Sarre S, Diltoer M, Piacentini MF, Michotte Y. Acute dopamine/norepinephrine reuptake inhibition increases brain and core temperature in rats. J Appl Physiol 2005;99:1397-401.

Moezi L, Shafaroodi H, Sarkar S, Emami-Razavi SH, Sanatkar M, Mirazi N, et al. Involvement of nitrergic and opioidergic systems in the hypothermia induced by cholestasis in rats. Pathophysiology 2006;13:227-32.

Cox B, Lee TF. Location of receptors mediating hypothermia after injection of dopamine agonists in rats. Br J Pharmacol 1977;59:467-68.

Rao VL, Gig uere JF, Laygurgues GP, Buttreworth RF. Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Brain Res 1993;621:349-52.

Nasehi M, Ahmadzadeh O, Rezayof A, Zarrindast MR. Does CA1 dopaminergic system play a role in cholestasis induced hypothermia? Pathophysiology 2013b;20:181-9.

Barros RC, Branco LG, Carnio E. Evidence for thermoregulation by dopamine D1 and D2 receptors in the anteroventral preoptic region during normoxia and hypoxia. Brain Res 2004;1030:165-71.

Lin MT, Chandra A, Tsay BL, Chern YF. Hypothalamic and striatal dopamine receptor activation inhibits heat production in the rat. Am J Physiol 1982;242:R471-81.

Arnt J, Bøgesø K.P, Hyttel J, Meier E. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Pharmacol Toxicol 1988;62:121-30.

Arnt J, Hyttel J, Meier E. Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats. Eur J Pharmacol 1988;155.

Zarrindast MR, Issazadeh Y, Rezaei N, Khakpai F. Possible involvement of the opioidergic system in the modulation of body temperature, jumping behavior and memory process in cholestatic and addicted mice. EXCLI J 2020;19:311-22.

Glick SD, Marsanico RG. Apomorphine-induced and pilocarpine-induced hypothermia in mice: drug interactions and changes in drug sensitivity after caudate nucleus lesions. Br J Pharmacol 1974;51:353-7.